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Abstract: Adenoid cystic carcinoma (ACC) is a rare low-grade malignant epithelial tumor that usually originates in the salivary glands.
It shows a slow progression and metastasizes rarely. A 74-year-old male patient was admitted to our clinic due to pulmonary lesions
seen on a chest-X ray coincidentally. The patient, 6 years before admission, was operated on for a peptic ulcer perforation and a right
hilar mass lesion, and bibasilar pulmonary nodular lesions were also found on his chest radiograph. A bronchoscopic biopsy revealed
ACC and surgical treatment was offered to the patient; however, he refused it. The patient, who had a 130-pack-year smoking history,
was asymptomatic on admission to our clinic. Since metastatic pulmonary lesions were present, the patient was diagnosed with stage
IV lung cancer and given chemotherapy. Thorax computerized tomography, performed after treatment, revealed no change in the size
or number of pulmonary lesions, and the patient has been followed since then and is still asymptomatic. This case of metastatic ACC
was reported, after a review of the literature, as being a rare case, as the patient revealed no symptoms from the time of diagnosis until
the end of treatment.
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1. Introduction
Adenoid cystic carcinoma (ACC) shows distinct
histopathological and clinical features, and it arises most
commonly in the major and minor salivary glands and less
commonly in other sites such as the breast, skin, uterine
cervix, upper aerodigestive tract, and lungs (1). Primary
ACCs of the lung, which commonly occur in the trachea
and major bronchi, are very rare and account for only
0.09%–0.2% of all lung cancers (2).
The patient series of primary lung ACCs in the
literature comprises a small number of cases, and the
existing reports include limited data about the prevalence,
clinical course, and treatment modalities of the disease
and the response to treatment (3–15). The present case
was reported as being an interesting one, since primary
lung ACC is a very rare disease and since the patient was
asymptomatic from the time of diagnosis until the end of
treatment, although the disease showed an endobronchial
localization with pulmonary metastases.
2. Case report
A 74-year-old male patient was admitted to our clinic due
to pulmonary lesions seen coincidentally on a chest X-ray
(Figure 1a). The patient, 6 years before admission, was
operated on for peptic ulcer perforation and a right hilar
* Correspondence: dr.shule@hotmail.com

mass lesion, and bibasilar pulmonary nodular lesions were
also found on his chest radiograph. Thorax computerized
tomography (CT) performed at that time revealed similar
lesions and a bronchoscopy was performed. During the
bronchoscopic examination, a necrotic endobronchial
lesion obstructing the right middle lobe bronchus was
seen. The bronchoscopic biopsy of the lesion revealed an
ACC and surgical treatment was offered to the patient;
however, he refused.
The patient, who had a 130-pack-year smoking history,
was asymptomatic on admission and had no coexisting
diseases. The vital signs, physical examination, and
laboratory findings were all normal. Thorax CT showed a
right hilar mass and an accompanying atelectatic region
as well as bibasilar nodular lesions (Figure 1b). The
bronchoscopic biopsy specimens were reexamined and
reported as an ACC (Figure 2). There was no metastasis
seen upon abdominal and cranial CT examination. Bone
scintigraphy showed an intense uptake of Tc-99m MDP
in the thoracal vertebrae. Thoracal magnetic resonance
imaging revealed prominent compression and loss of
altitude of the 6th, 8th, and 10th vertebrae. Since the patient
had a history of trauma, the neurosurgical consultation
concluded that the patient did not have metastatic lesions
but rather lesions due to trauma.
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Figure 1. Chest X-ray (a) and thorax CT (b) on admission, revealing a right hilar mass and an accompanying atelectatic region, as well
as bibasilar nodular lesions.

considered to have a stable disease and was admitted to a
follow-up program.

Figure 2. Tumor cells usually showing a cribriform pattern
and having narrow cytoplasm with oval–round nuclei in the
basophilic material (hematoxylin and eosin, 200×).

Although the radiological examinations of the reported
patient at the time of diagnosis could not be obtained,
it was considered that the patient had no metastasis in
2004 since surgery was offered to him for treatment. In
the thorax CT performed in 2006, there were 2 metastatic
lesions in the right lower lobe. The number and size of the
metastatic lesions were found to have increased during the
follow-up, although the patient was still asymptomatic.
Due to the patient having metastatic pulmonary lesions,
he was evaluated as having stage IV lung cancer and a
chemotherapy regimen (cisplatin and gemcitabine) was
prescribed. The patient, who had no change in the number
and size of metastatic nodules after the therapy, was
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3. Discussion
ACC, which shows a slow progression and has a high longterm survival rate, is generally considered as a low-grade
malignancy. Primary lung ACC affects both sexes equally
and tends to occur in the 4th and 5th decades of life
(16,17). The development of the disease has no association
with cigarette smoking or other carcinogens (17,18).
The tumor has 3 major histopathologic growth
patterns, namely cribriform, tubular, and solid. The most
commonly found subtype is the cribriform pattern, which
was also diagnosed in our case (17). Tumors with solid
patterns have the worst differentiation and prognosis
(16,17). However, there remains no definite relation
between histologic subgroup and prognosis. In one of
the studies investigating the relation between histologic
subgroup and survival, a correlation was detected, whereas
in others, no correlation was found (3,10,12).
The patients with centrally located ACC are usually
asymptomatic on admission (4,7,9,10,17,18). Most
patients with lung ACCs in the patient series by Moran
et al. had symptoms due to obstructive pathology such as
cough, wheezing, dyspnea, and hemoptysis (10). Although
primary lung ACCs mostly affect the trachea and major
bronchi, they may present as peripheral masses, or with
Pancoast syndrome (15,19,20). Patients with peripheral
ACCs in the literature were usually reported to be
asymptomatic and the ACCs were seen on chest X-rays
incidentally (15). The reported patient, although having
a centrally located lesion, was asymptomatic both on
admission and during follow-up.
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Primary lung ACCs, which were initially classified as
bronchial adenomas, are slow-growing, unencapsulated
malignant tumors that tend to invade the perineural and
submucosal region (4). Perineural invasion is seen in 40%
of cases and the tumor characteristically extends along
vascular structures, bronchi, bronchioles, and lymphatics
(17,18). The disease may involve regional lymph nodes,
usually with direct extension. High-grade tumors are
much more aggressive and tend to spread radially into the
adjacent lung parenchyma rather than along the airways
(16). The metastases that are usually seen in the late stages
of the disease mostly involve the lung, bone, liver, brain,
and mediastinal lymph nodes (17,18).
The primary treatment modality for primary lung
ACC is surgery. However, the difficulty of obtaining clear
surgical margins in most cases, due to perineural invasion,
increases the risk of local recurrence after resection
(17,18). There are some studies showing that the prognosis
is better in patients with primary lung ACC who were
treated surgically (7,9). In the study by Kanematsu et al.,
11 patients with primary lung ACC were treated surgically
and 5 patients were treated with radiotherapy because
of extensive tracheal invasion of the tumor in 4 patients
and poor pulmonary function for a pneumonectomy
in 1 patient. The 5-year and 10-year survival rates were
91% and 76% in the resected group and 40% and 0%
in the nonresected group, respectively. In the resected
group, 3 patients died. On the other hand, all patients
died in the nonresected group (7). In another study that
investigated the effect of surgical resection on prognosis,
the survival rate for surgical patients with primary lung
ACC was 73% at 3 years, 57% at 5 years, and 45% at 10
years. On the other hand, the survival rate for nonsurgical
patients with primary lung ACC was 74% at 3 years, 53%
at 5 years, and 31% at 10 years. The difference in survival
between surgical and nonsurgical patients was statistically
significant (P < 0.01). Researchers suggest that complete
surgical resection, when achievable, provides patients
with the best chance of long-term survival (9). However,
the patients who were treated nonsurgically or underwent
incomplete surgical resection had advanced disease, and
so rendering these results was difficult.
Since ACCs have a propensity to spread submucosally
and perineurally, adjuvant radiotherapy is routinely
recommended in all resectable tumors of this cell type
(11). Although primary radiotherapy is recommended for
inoperable patients, the role of radiotherapy in the primary
management of this tumor is still controversial. Gelder and
Hetzel reported 34 cases of tracheal ACC treated either with
surgical resection or primary radiotherapy. No difference
in survival was observed between the 2 treatment groups

at the 5- and 10-year follow-ups (5). On the other hand,
Grillo and Mathisen described significant improvement
in median survival with complete resection followed by
postoperative irradiation, as opposed to radiotherapy
alone. They reported a median survival time of 118 months
with resection and postoperative irradiation, compared
with 28 months with radiotherapy alone (6). Maziak et al.
reviewed their experience with 38 patients with ACC of
the upper airway. Of the 38 patients, 32 were treated by
surgical resection and reconstruction. The other 6 patients,
with unresectable tumors, were treated with radiotherapy
alone. Of the 32 patients undergoing resection, 26
received adjuvant radiotherapy. Local recurrence of the
primary tumor in the airway was documented in 8 of the
32 patients. In contrast, 5 of the 6 patients treated with
primary radiotherapy had local recurrence. There was no
significant difference in mean survival between these 2
categories. Of the patients who had residual tumor after
resection, 16 had a mean survival of 90 months and the
other 16 patients, with complete resection and negative
margins, had a mean survival of 119 months; there was no
significant difference in these survival data. Although the
survival differences did not reach statistical significance,
the authors pointed out the trend for increased survival
in the group undergoing complete resection, particularly
at 10 years: complete resection of 69% and incomplete
resection of 30%. They therefore suggested that adjuvant
radiotherapy might have an effect on survival (8).
The role of chemotherapy in the treatment of metastatic
lung ACC is controversial (14). The reported case, due to
presence of metastatic pulmonary lesions, was evaluated
as stage IV lung cancer and a chemotherapy regimen was
prescribed by the Medical Oncology Department. Since the
patient had no change in the number and size of metastatic
nodules after 4 cycles of therapy, he was considered to have
a stable disease and was admitted to a follow-up program.
In conclusion, primary lung ACC has a better
survival rate than the other lung cancers. In the early
stages, surgical resection is the first choice of treatment,
especially for the tracheal adenoid cystic carcinoma. Since
these tumors have a propensity to spread submucosally
and perineurally, adjuvant radiotherapy is routinely
recommended in all resectable tumors of this cell type.
Although primary radiation therapy is recommended
for patients who have inoperable lesions, the benefit of
radiotherapy is controversial. In advanced stages, there
is no consensus about which chemotherapeutic agent to
choose, and therefore the side effects of the agent should
be considered before prescription. For asymptomatic
patients, follow-up programs with the best supportive care
possible may also be considered.
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